178 related articles for article (PubMed ID: 18058201)
1. EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: characterization and in vitro evaluation.
Cao H; Xu SY
J Mater Sci Mater Med; 2008 Feb; 19(2):567-75. PubMed ID: 18058201
[TBL] [Abstract][Full Text] [Related]
2. The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering.
Chang KY; Hung LH; Chu IM; Ko CS; Lee YD
J Biomed Mater Res A; 2010 Feb; 92(2):712-23. PubMed ID: 19274722
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate.
Pieper JS; Oosterhof A; Dijkstra PJ; Veerkamp JH; van Kuppevelt TH
Biomaterials; 1999 May; 20(9):847-58. PubMed ID: 10226711
[TBL] [Abstract][Full Text] [Related]
4. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
[TBL] [Abstract][Full Text] [Related]
5. Construction of collagen II/hyaluronate/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering and preliminary analysis of its physico-chemical properties and biocompatibility.
Li CQ; Huang B; Luo G; Zhang CZ; Zhuang Y; Zhou Y
J Mater Sci Mater Med; 2010 Feb; 21(2):741-51. PubMed ID: 19763796
[TBL] [Abstract][Full Text] [Related]
6. Collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering.
Huang B; Li CQ; Zhou Y; Luo G; Zhang CZ
J Biomed Mater Res B Appl Biomater; 2010 Feb; 92(2):322-31. PubMed ID: 19802835
[TBL] [Abstract][Full Text] [Related]
7. Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro.
van Susante JLC ; Pieper J; Buma P; van Kuppevelt TH; van Beuningen H; van Der Kraan PM; Veerkamp JH; van den Berg WB; Veth RPH
Biomaterials; 2001 Sep; 22(17):2359-69. PubMed ID: 11511033
[TBL] [Abstract][Full Text] [Related]
8. The effect of different cross-linking conditions of EDC/NHS on type II collagen scaffolds: an in vitro evaluation.
Nong LM; Zhou D; Zheng D; Jiang YQ; Xu NW; Zhao GY; Wei H; Zhou SY; Han H; Han L
Cell Tissue Bank; 2019 Dec; 20(4):557-568. PubMed ID: 31583486
[TBL] [Abstract][Full Text] [Related]
9. Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering.
Pieper JS; van der Kraan PM; Hafmans T; Kamp J; Buma P; van Susante JL; van den Berg WB; Veerkamp JH; van Kuppevelt TH
Biomaterials; 2002 Aug; 23(15):3183-92. PubMed ID: 12102190
[TBL] [Abstract][Full Text] [Related]
10. Designed composites for mimicking compressive mechanical properties of articular cartilage matrix.
Zhu Y; Wu H; Sun S; Zhou T; Wu J; Wan Y
J Mech Behav Biomed Mater; 2014 Aug; 36():32-46. PubMed ID: 24793172
[TBL] [Abstract][Full Text] [Related]
11. The modification of scaffold material in building artificial dermis.
Zhang L; Ma D; Wang F; Zhang Q
Artif Cells Blood Substit Immobil Biotechnol; 2002 Jul; 30(4):319-32. PubMed ID: 12227650
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering.
Chang KY; Cheng LW; Ho GH; Huang YP; Lee YD
Acta Biomater; 2009 Jul; 5(6):1937-47. PubMed ID: 19282262
[TBL] [Abstract][Full Text] [Related]
13. Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering.
Lai JY; Li YT; Cho CH; Yu TC
Int J Nanomedicine; 2012; 7():1101-14. PubMed ID: 22403490
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic porous scaffolds made from poly(L-lactide)-g-chondroitin sulfate blend with poly(L-lactide) for cartilage tissue engineering.
Lee CT; Huang CP; Lee YD
Biomacromolecules; 2006 Jul; 7(7):2200-9. PubMed ID: 16827588
[TBL] [Abstract][Full Text] [Related]
15. Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold.
Lee JE; Kim KE; Kwon IC; Ahn HJ; Lee SH; Cho H; Kim HJ; Seong SC; Lee MC
Biomaterials; 2004 Aug; 25(18):4163-73. PubMed ID: 15046906
[TBL] [Abstract][Full Text] [Related]
16. Effects of exogenous glycosaminoglycans on human chondrocytes cultivated on type II collagen scaffolds.
Wu CH; Ko CS; Huang JW; Huang HJ; Chu IM
J Mater Sci Mater Med; 2010 Feb; 21(2):725-9. PubMed ID: 19823917
[TBL] [Abstract][Full Text] [Related]
17. Construction and biocompatibility of a thin type I/II collagen composite scaffold.
Han L; Zhang ZW; Wang BH; Wen ZK
Cell Tissue Bank; 2018 Mar; 19(1):47-59. PubMed ID: 28808811
[TBL] [Abstract][Full Text] [Related]
18. Corneal stromal cell growth on gelatin/chondroitin sulfate scaffolds modified at different NHS/EDC molar ratios.
Lai JY
Int J Mol Sci; 2013 Jan; 14(1):2036-55. PubMed ID: 23337203
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering.
Daamen WF; van Moerkerk HT; Hafmans T; Buttafoco L; Poot AA; Veerkamp JH; van Kuppevelt TH
Biomaterials; 2003 Oct; 24(22):4001-9. PubMed ID: 12834595
[TBL] [Abstract][Full Text] [Related]
20. [Fabrication and properties of a composite chitosan/type II collagen scaffold for tissue engineering cartilage].
Shi D; Cai D; Zhou C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Apr; 19(4):278-82. PubMed ID: 15921318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
